XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Scumbag CEO's on Ventures, Manipulate price to get Shrhldrs

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Jun 15, 2021 11:28am

87 Views

Post# 33388436

RE:RE:RE:RE:RE:RE:RE:Scumbag CEO's on Ventures, Manipulate price to get Shrhldrs

KOkidneydisease wrote: although, I'm trying to undertsand todays volume and drop in price. I'm sure it's just noise.

NO NEWS about progress from CEO Allen in a LONG TIME.

Can he update on any progress to shrhldrs pls,,,,,,,or step down and let someone else take charge while he looks after Science to get things rolling again.

PATHETIC performance since last 25c PP

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver